Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...
Karolinska Institutet accounts for the single largest share of all academic medical research conducted in Sweden. The research spans the entire biomedical field – from basic experimental research to ...
As one of the world’s foremost medical universities, KI accounts for the single largest share of all academic medical research conducted in Sweden. KI also offers the country’s broadest range of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback